Publicacions en què col·labora amb Catalina Santiago Dorrego (31)

2019

  1. Muscle Fitness Cut Points for Early Assessment of Cardiovascular Risk in Children and Adolescents

    Journal of Pediatrics, Vol. 206, pp. 134-141.e3

2017

  1. Cardiorespiratory Fitness Cutoff Points for Early Detection of Present and Future Cardiovascular Risk in Children: A 2-Year Follow-up Study

    Mayo Clinic Proceedings, Vol. 92, Núm. 12, pp. 1753-1762

  2. Convergent validation of a questionnaire to assess the mode and frequency of commuting to and from school

    Scandinavian Journal of Public Health, Vol. 45, Núm. 6, pp. 612-620

2016

  1. Inflammatory biomarkers and academic performance in youth. The UP & DOWN Study

    Brain, Behavior, and Immunity, Vol. 54, pp. 122-127

  2. Perceived environment in relation to objective and self-reported physical activity in Spanish youth. The UP&DOWN study

    Journal of Sports Sciences, Vol. 34, Núm. 15, pp. 1423-1429

2015

  1. Objectively measured and self-reported leisure-time sedentary behavior and academic performance in youth: The UP&DOWN Study

    Preventive Medicine, Vol. 77, pp. 106-111

2014

  1. Are serotonergic system genes associated to smoking cessation therapy success in addition to CYP2A6 ?

    Pharmacopsychiatry, Vol. 47, Núm. 1, pp. 33-36

2011

  1. 'Smoking Genes': A genetic association study

    PLoS ONE, Vol. 6, Núm. 10

2010

  1. A novel, single algorithm approach to predict acenocoumarol dose based on CYP2C9 and VKORC1 allele variants

    PLoS ONE, Vol. 5, Núm. 6

  2. ACE and ACTN3 genes and muscle phenotypes in nonagenarians

    International Journal of Sports Medicine, Vol. 31, Núm. 4, pp. 221-224

  3. CYP2D6 polymorphism screening in a selected population of Spain (La Alpujarra): No effect of geographical isolation

    Annals of Human Biology, Vol. 37, Núm. 2, pp. 267-273

  4. The K153R variant in the myostatin gene and sarcopenia at the end of the human lifespan

    Age, Vol. 32, Núm. 3, pp. 405-409

2009

  1. Does the K153R variant of the myostatin gene influence the clinical presentation of women with McArdle disease?

    Neuromuscular Disorders, Vol. 19, Núm. 3, pp. 220-222

  2. Endurance performance: Genes or gene combinations?

    International Journal of Sports Medicine, Vol. 30, Núm. 1, pp. 66-72

  3. Genotype distributions in top-level soccer players: A role for ace ?

    International Journal of Sports Medicine, Vol. 30, Núm. 5, pp. 387-392

  4. Is there an optimum endurance polygenic profile?

    Journal of Physiology, Vol. 587, Núm. 7, pp. 1527-1534

  5. Pharmacogenetics of acenocoumarol: CYP2C9 *2 and VKORCI c.-l 639G>A, 497C>G, 1173C>T, and 3730G>A variants influence drug dose in anticoagulated patients

    Thrombosis and Haemostasis, Vol. 101, Núm. 3, pp. 591-593

  6. The -786 T/C polymorphism of the NOS3 gene is associated with elite performance in power sports

    European Journal of Applied Physiology, Vol. 107, Núm. 5, pp. 565-569

  7. The C allele of the AGT Met235Thr polymorphism is associated with power sports performance

    Applied Physiology, Nutrition and Metabolism, Vol. 34, Núm. 6, pp. 1108-1111

  8. Unique among unique. Is it genetically determined?

    British Journal of Sports Medicine, Vol. 43, Núm. 4, pp. 307-309